HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Arnold Spek Selected Research

Myocardial Infarction

4/2010Markers of inflammation and coagulation indicate a prothrombotic state in HIV-infected patients with long-term use of antiretroviral therapy with or without abacavir.
3/2005High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Arnold Spek Research Topics

Disease

36Neoplasms (Cancer)
02/2022 - 01/2004
19Inflammation (Inflammations)
01/2022 - 01/2003
12Fibrosis (Cirrhosis)
01/2021 - 02/2008
12Neoplasm Metastasis (Metastasis)
01/2021 - 01/2004
10Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2022 - 12/2010
10Pancreatic Neoplasms (Pancreatic Cancer)
02/2022 - 07/2010
9Sepsis (Septicemia)
09/2007 - 01/2003
8Infections
11/2016 - 08/2006
7Adenocarcinoma
01/2022 - 07/2010
7Disease Progression
04/2020 - 10/2008
6Diabetic Nephropathies (Diabetic Nephropathy)
10/2019 - 01/2016
5Idiopathic Pulmonary Fibrosis
07/2018 - 12/2010
5Disseminated Intravascular Coagulation
11/2007 - 01/2003
4Pneumonia (Pneumonitis)
01/2022 - 10/2005
4Bacterial Infections (Bacterial Infection)
05/2015 - 02/2010
4Shwartzman Phenomenon (Shwartzman Reaction)
11/2007 - 01/2003
4Thrombosis (Thrombus)
10/2007 - 11/2003
4Endotoxemia
12/2006 - 01/2003
3Lung Diseases (Lung Disease)
01/2022 - 06/2015
3Pneumococcal Pneumonia
11/2018 - 06/2006
3Hemorrhage
03/2017 - 01/2008
3Colonic Neoplasms (Colon Cancer)
06/2010 - 01/2009
3Cardiovascular Diseases (Cardiovascular Disease)
04/2010 - 03/2005
2Acute Lung Injury
01/2022 - 04/2013
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2019 - 01/2017
2Hyperglycemia
04/2018 - 10/2007
2Venous Thrombosis (Deep-Vein Thrombosis)
08/2015 - 08/2006
2Lymphatic Metastasis
05/2015 - 11/2014
2Ischemia
01/2013 - 09/2007
2Melanoma (Melanoma, Malignant)
01/2013 - 01/2009
2Atherosclerotic Plaque (Atheroma)
09/2012 - 10/2006
2Breast Neoplasms (Breast Cancer)
09/2012 - 06/2010
2Colitis
09/2011 - 09/2007
2Myocardial Infarction
04/2010 - 03/2005
2Fever (Fevers)
02/2010 - 02/2010
2Reperfusion Injury
07/2009 - 09/2007
2Myocardial Ischemia (Ischemic Heart Diseases)
07/2009 - 08/2008
2Osteosarcoma (Osteogenic Sarcoma)
05/2009 - 12/2003
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2009 - 09/2007
2Vascular System Injuries
01/2008 - 01/2003
2Carotid Artery Thrombosis
10/2007 - 11/2003
2Peritonitis
08/2006 - 06/2004
2Necrosis
08/2006 - 06/2005
2Multiple Organ Failure (MODS)
06/2005 - 01/2003

Drug/Important Bio-Agent (IBA)

19Peptide Hydrolases (Proteases)FDA Link
01/2022 - 11/2007
14Thromboplastin (Tissue Factor)IBA
11/2018 - 11/2003
13Proteinase-Activated ReceptorsIBA
12/2020 - 01/2008
13ThrombinFDA Link
10/2020 - 06/2004
11AnticoagulantsIBA
10/2020 - 06/2004
10Bleomycin (Blenoxane)FDA LinkGeneric
06/2022 - 12/2010
10Protein CIBA
01/2016 - 08/2006
9Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2004
9Transcription Factors (Transcription Factor)IBA
01/2021 - 07/2006
8Blood Coagulation Factors (Coagulation Factor)IBA
08/2015 - 01/2005
7PAR-2 ReceptorIBA
11/2018 - 03/2010
6CCAAT-Enhancer-Binding Protein-deltaIBA
01/2021 - 12/2012
6CCAAT-Enhancer-Binding ProteinsIBA
09/2020 - 09/2007
6CytokinesIBA
01/2019 - 06/2003
6Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
08/2015 - 06/2005
6FibrinIBA
09/2011 - 06/2004
5Hydroxyproline (4 Hydroxyproline)IBA
01/2021 - 02/2014
5Factor VIIa (Activated Factor VII)IBA
11/2018 - 01/2004
5Factor Xa (Coagulation Factor Xa)IBA
06/2010 - 07/2007
5EndotoxinsIBA
03/2010 - 03/2004
5Dacarbazine (DIC)FDA LinkGeneric
11/2007 - 01/2003
4Messenger RNA (mRNA)IBA
12/2019 - 03/2005
4Streptozocin (Streptozotocin)FDA Link
04/2018 - 10/2007
4C-Reactive ProteinIBA
04/2010 - 03/2005
3GemcitabineFDA Link
01/2022 - 03/2017
3Pharmaceutical PreparationsIBA
07/2021 - 08/2006
3Biomarkers (Surrogate Marker)IBA
04/2020 - 03/2005
3CollagenIBA
07/2018 - 10/2007
3AntithrombinsIBA
03/2017 - 06/2004
3LigandsIBA
09/2012 - 01/2009
3factor V LeidenIBA
12/2008 - 08/2006
3Interleukin-6 (Interleukin 6)IBA
10/2007 - 08/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2007 - 08/2006
2DNA (Deoxyribonucleic Acid)IBA
06/2022 - 01/2021
2Silicon Dioxide (Silica)FDA LinkGeneric
02/2022 - 07/2021
2platelet activating factor receptorIBA
01/2021 - 06/2012
2Metalloproteases (Metalloproteinases)IBA
04/2020 - 01/2013
2Blood Glucose (Blood Sugar)IBA
10/2019 - 10/2007
2vorapaxarIBA
10/2019 - 04/2018
2Fibronectins (Fibronectin)IBA
07/2018 - 04/2018
2ThrombomodulinIBA
09/2011 - 11/2003
2cyclopamineIBA
07/2010 - 08/2008
2Factor X (Stuart Factor)IBA
06/2010 - 06/2009
2Fibrinogen (Factor I)FDA Link
04/2010 - 01/2009
2Factor VIII (Coagulation Factor VIII)IBA
04/2010 - 12/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2010 - 05/2009
2HirudinsIBA
06/2009 - 01/2009
2ferric chlorideIBA
10/2007 - 11/2003
2CreatinineIBA
09/2007 - 06/2005
2antithrombin III-protease complexIBA
08/2006 - 06/2006
1Interleukin-4 (Interleukin 4)IBA
06/2022
1MethyltransferasesIBA
06/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2022
1Fluorouracil (Carac)FDA LinkGeneric
01/2022

Therapy/Procedure

8Therapeutics
10/2020 - 07/2009
2Drug Therapy (Chemotherapy)
02/2022 - 01/2022